C

Centro Reumatologico de Caguas | Caguas, PR

Research site

(Unclaimed)

Location

M36 calle 13 Urb. Condado Moderno, Caguas, Puerto Rico, United States of America

Site insights

Top conditions

Top treatments

Cenerimod

Guselkumab

Nerandomilast

Ixekizumab

Obexelimab

ESK-001

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 7 total trials

A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus (OPUS-2)

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematous in adult patients with moderate to sever...

Enrolling

Lupus Erythematosus, Systemic

Drug: Cenerimod

Drug: Placebo

A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001 (ONWARD2)

The goal of this clinical trial is to learn if ESK-001 works to treat moderate to severe plaque psoriasis. The main questions it aims to answer are:*...

Enrolling

Plaque Psoriasis

Drug: ESK-001

Drug: Placebo

Locations recently updated

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus (SunStone)

This study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE).

Enrolling

Systemic Lupus Erythematosus

Drug: Placebo

Drug: Obexelimab

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

Adults 18 years of age and older or above legal age with lung fibrosis related to systemic autoimmune rheumatic disease can participate in this study...

Begins enrollment in 1 month

Interstitial Lung Diseases

Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases

Drug: Nerandomilast

Drug: Placebo matching nerandomilast